Mount Sinai Halts Pediatric Gender Procedures Under Justice Department Agreement as New York Sues

Hospital administrators at Mount Sinai Health System have signed a binding agreement with the Department of Justice to immediately cease providing gender-affirming medical treatments to minors. The September 4, 2026, settlement resolves a federal civil rights investigation but triggers an immediate collision with state authorities, who mandate that such care remain accessible.[1][4]

Under the terms of the agreement, Mount Sinai will establish a specific financial trust. The Daily Signal reported this fund is designed to "Provide $2M in Care for Patients Harmed by Pediatric Gender Interventions." The hospital system faced the total loss of its federal Medicare and Medicaid reimbursements if it refused the compliance terms.[1]

New York Attorney General Letitia James responded on September 2, 2026, by filing a preemptive lawsuit aimed at shielding transgender youth and their medical providers from federal interference. Her office's official statement declared that "Attorney General James Sues to Protect Gender-Affirming Care for Transgender Youth," warning that hospitals altering their medical offerings based on federal pressure are violating New York's human rights laws.[2]

The federal pressure campaign extends beyond New York into at least one other New England state. In neighboring Connecticut, state lawmakers are preparing to issue subpoenas to executives at Connecticut Children's Medical Center following reports that the hospital struck a similar compliance deal. The CT Mirror reported that legislators could "subpoena CT Children's over gender care deal with Trump."[3]

Connecticut legislators expressed alarm that hospital boards are negotiating private settlements that alter the state's healthcare landscape without public oversight. The potential subpoenas would compel the hospital leadership to disclose the exact terms demanded by federal investigators and the specific financial threats leveraged against the institution.[3]

The Justice Department formally announced on September 4 that it "Secures Agreement with Mount Sinai to End Pediatric 'Gender-Affirming Care.'" The federal agency frames the interventions—which include puberty blockers and cross-sex hormones for adolescents—as experimental, utilizing civil rights statutes to mandate the cessation of the protocols across federally funded institutions.[1]

For the patients currently enrolled in pediatric gender clinics at these specific institutions, the agreements force an abrupt transition of care. Medical teams must now navigate how to safely taper medications or transfer adolescents to independent, non-federally funded clinics, though such independent clinics are increasingly rare.[4]

The legal standoff now moves to federal court in the Southern District of New York, where a judge will have to reconcile the Justice Department's funding conditions with the state's anti-discrimination statutes. Until a preliminary injunction is granted or denied, hospital compliance officers remain caught between two competing legal directives: the threat of federal defunding and state-level prosecution.[2][4]